L-Arginine ameliorates recirculation and metabolic derangement in brain ischemia in hypertensive rats

Brain Research

Volumn 744, Issue 2, 1997, Pages 246-252

  Sadoshima, Seizo ^a   Nagao, Tetsuhiko ^a   Okada, Yasushi ^a   Fujii, Kenichiro ^a   Ibayashi, Setsuro ^a   Fujishima, Masatoshi ^a  

^a KYUSHU UNIVERSITY   (Japan)

Author keywords

brain ischemia; hypertensive rat; L arginine; N( ) nitro L arginine; reperfusion

Indexed keywords

ARGININE; N(G) NITROARGININE; NITRIC OXIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN BLOOD FLOW; BRAIN ISCHEMIA; BRAIN METABOLISM; CAROTID ARTERY OBSTRUCTION; CONTROLLED STUDY; INTRAVENOUS DRUG ADMINISTRATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SPONTANEOUSLY HYPERTENSIVE RAT;

ANIMALS; ARGININE; BRAIN ISCHEMIA; CEREBROVASCULAR CIRCULATION; HYPERTENSION; MALE; RATS; RATS, INBRED SHR; VASCULAR RESISTANCE;

EID: 0031035684     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(96)01063-3     Document Type: Article

References (44)

1. Ashwal, S., Cole, D.J., Osborne, T.N. and Pearce, W.J., Dual effects of L-NAME during transient focal cerebral ischemia in spontaneously hypertensive rats, Am. J. Physiol., 267 (1994) H276-H284.
2. Aukland, K., Bower, B.F. and Berliner, R.W., Measurement of local blood flow with hydrogen gas, Circ. Res., 14 (1964) 164-187.
3. Bonita, R., Stewart, A.W. and Beaglehole, R., International trends in stroke mortality: 1970-1985, Stroke. 21 (1990): 989-992.
4. Broderick, J.P., Hagen, T., Brott, T. and Tomsick, T., Hyperglycemia and hemorrhagic transformation of cerebral infarcts, Stroke, 26 (1995) 484-487.
5. Bult, H., Boeckxstaens, G.E., Pelckmans, P.A., Jordaens, F.H., Van Maercke, Y.M. and Herman, A.G., Nitric oxide as an inhibitory non-adrenergic non-cholinergic neurotransmitter, Nature, 345 (1990) 346-347.
6. Carmerlingo, M., Casto, L., Censori, B., Ferraro, B., Gazzaniga, G.C., Cesana, B. and Mamoli, A., Immediate anticoagulation with heparin for first-ever ischemic stroke in the carotid artery territories observed within 5 hours of onset. Arch. Neural., 51 (1994) 462-467.
7. Clavier, N. and Kirsch, J., Cerebral blood flow is reduced by Nω-nitro-L-arginine methyl ester during delayed hypoperfusion in cats, Am. J. Physiol., 267 (1994) H174-H181.
8. Floyd, R.A. and Carney, J.M., Free radical damage to protein and DNA: mechanisms involved and relevant observations on brain undergoing oxidative stress, Ann. Neurol., 32 (1992) s22-s27.
9. Fujii. K., Sadoshima, S., Yao, H., Yoshida, F., Iwase, M. and Fujishima, M, Cerebral ischemia in spontaneously hypertensive rats with type 2 (noninsulin-dependent) diabetes mellitus, cerebral blood flow and tissue metabolism, Gerontology, 35 (1989) 78-87.
10. Fujishima, M., Ogata, J., Sugi, T. and Omae, T., Mortality and cerebral metabolism after bilateral carotid artery ligation in normotensive and spontaneously hypertensive rats, J. Neurol. Neurosurg. Psychiatry, 39 (1976) 212-217.
11. Golanov, E.V. and Reis, D.J., Nitric oxide and prostanoids participate in cerebral vasodilation elicited by electrical stimulation of the rostral ventrolateral medulla, J. Cereb. Blood Flow Metab., 14 (1994) 492-502.
12. He, Z., Ibayashi, S., Fujii, K., Sadoshima, S. and Fujishima, M., L-Arginine ameriolates cerebral blood flow and metabolism and decreases infarct volume in rats with cerebral ischemia, Brain Res., 699 (1995) 208-213.
13. 2+ in cultured rat forebrain neurons, Brain Res., 592 (1992) 310-316.
14. Iadecola, C., Beitz, A.M., Renno, W., Xu, X., Mayer, B. and Zhang, F., Nitric oxide synthase containing neuronal precess on large cerebral arteries and microvessels, Brain Res., 606 (1993) 148-155.
15. Iadecola, C., Pelligrino, D.A., Moskowitz, M.A. and Lassen, N.A., Nitric oxide synthase inhibition and cerebrovascular regulation, J. Cereb. Blood Flow Metab., 14 (1994) 175-192.
16. Iadecola, C., Zhang, F., Xu, S., Casey, R. and Ross, M.E., Inducible nitric oxide synthase gene expression in brain following cerebral ischemia, J. Cereb. Blood Flow Metab., 15 (1995) 378-384.
17. Kanwar, S. and Kubes, P., Nitric oxide is an antiadhesive molecule for leukocyte, New Horizons, 3 (1995) 93-104.
18. G-Nitro-L-arginine delays the development of brain injury during focal ischemia in rats, Stroke, 26 (1995) 282-289.
19. Kubes, P., Suzuki, M. and Granger, D.N., Nitric oxide: an endogenous modulator of leukocyte adhesion, Proc. Natl. Acad. Sci. USA, 88 (1991) 4651-4655.
20. Kumura, E., Kosaka, H., Shiga, T., Yoshimine, T. and Hayakawa, T., Elevation of plasma nitric oxide end products during focal cerebral ischemia and reperfusion in the rat, J. Cereb. Blood Flow Metab., 14 (1994) 487-491.
21. Lyden, P.D., Zivin, J.A., Clark, W.A., Madden, K., Sasse, K.C., Mazzarella, V.A., Terry, R.D. and Press, G.A., Tissue plasminogen activator-mediated thrombolysis of cerebral emboli and its effect on hemorrhagic infarction in rabbits, Neurology, 39 (1989) 703-708.
22. Minematsu, M., Yamagichi, T. and Omae, T., 'Spectacular shrinking deficit': rapid recovery from a major hemispheric syndrome by migration of an embolus, Neurology, 42 (1992) 157-162.
23. Moncada, S., The 1991 Ulf von Euler lecture. The L-arginine: nitric oxide pathway, Acta Physiol. Scand., 145 (1992) 201-227.
24. Mori, E., Yoneda, Y., Tabuchi, M., Yoshida, T., Ohkawa, S., Ohsumi, Y., Kitano, K., Tsutsumi, A. and Yamadori, A., Intravenous recombinant tissue plasminogen activator in acute carotid territory stroke, Neurology, 42 (1992) 976-982.
25. Morikawa, E., Huang, Z. and Moskowitz, M.A., L-Arginine decreases infarct size caused by middle cerebral occlusion in SHR, Am. J. Physiol, 263 (1992) H1632-H1635.
26. Muhonen, M.G., Heistad, D.D., Faraci, F.M. and Loftus C.M., Augmentation of blood flow through cerebral collaterals by inhibition of nitric oxide synthase, J. Cereb. Blood Flow Metab., 14 (1994) 704-714.
27. Okada, Y., Sadoshima, S., Saku, Y., Kitazono, T., Irie, K., Ogasawara, T., Utsunomiya, H. and Fujishima, M., Influence of hemorrhagic transformation on the outcome of thrombolytic therapy for patients with acute brain embolism, Neurol. Res., 14 (1992) 167-169.
28. Ostfeld, A.M. and Wilk, E. Epidemiology of stroke, 1980-1990: a progress report, Epidemiol. Rev., 12 (1990) 253-256.
29. Prado, R., Watson, B.D., Kuluz, J., Dietrich, W.D., Endothelium-derived nitric oxide synthase inhibition: effects on cerebral blood flow, pial artery diameter, and vascular morphology in rats, Stroke, 23 (1992) 1118-1124.
30. Prado, R., Watson, B.D. and Wester, P., Effect of nitric oxide synthase inhibition on cerebral blood flow following bilateral carotid artery occlusion and recirculation in the rats, J. Cereb. Blood Flow Metab., 13 (1993) 720-723.
31. Rothrock, J.F., Clark, W.M. and Lyden, P.D., Spontaneous early improvement following ischemic stroke, Stroke, 26 (1995) 1358-1360.
32. Sadoshima, S., Fujii, K., Ooboshi, H., Ibayashi, S., Fujishima, M., Angiotensin converting inhibitors attenuate ischemic brain metabolism in hypertensive rats, Stroke, 24 (1993) 1561-1567.
33. Sadoshima, S., Nagao, T., Ibayashi, S. and Fujishima, M., Inhibition of angiotensin-converting enzyme modulates the autoregulation of regional cerebral blood flow in hypertensive rats, Hypertension, 23 (part 1) (1994) 781-785.
34. Sadoshima, S., Ibayashi, S., Fujii, K., Nagao, T., Sugimori, H. and Fujishima, M., Inhibition of acetylcholinesterase modulates the autoregulation of cerebral blood flow and attenuates ischcmic brain metabolism in hypertensive rats, J. Cereb. Blood Flow Metab., 15 (1995) 845-851.
35. G-Methyl-L-arginine, an inhibitor of L-arginine-derived nitric oxide synthesis, stimulates renal sympathetic nerve activity in vivo. A role for nitric oxide in the central regulation of sympathetic tone? Circ. Res., 70 (1992) 607-611.
36. Shahar, E., McGovern, P.G., Sprafka, M., Pankow, J.S., Doliszny, K.M., Luepker, R.V. and Blackburn, H., Improved survival of stroke patients during the 1980s. The Minnesota stroke survey, Stroke, 26 (1995) 1-6.
37. Shinkawa, A., Ueda, K., Kiyohara, Y., Kato, I., Sueishi, K., Tsuneyoshi, M. and Fujishima, M., Silent cerebral infarction in a community-based autopsy series in Japan. the Hisayama study, Stroke, 26 (1995) 380-385.
38. Statistics and information department, Minister's secretariat, Ministry of Health and Welfare General mortality, Vital Stat. Japan, 1 (1992) 132-139.
39. Tomimoto, H., Nishimura, M., Suenaga, T., Nakamura, S., Akiguchi, I., Wakita, H., Kimura, J. and Mayer, B., Distribution of nitric oxide synthase in the human vessels and brain tissues, J. Cereb. Blood Flow Metab., 14 (1994) 930-938.
40. Yamaguchi, T., Hayakawa, T. and Kikuchi, H., Intravenous tissue plasminogen activator ameliorates the outcome of hyperacute embolic stroke, Cerebrovasc. Dis., 3 (1993) 269-272.
41. Yamamoto, S., Golanov, E.V., Berger, S.B. and Reis, D.J., Inhibition of nitric oxide sysnthesis increases focal ischemic infarction in rat, J. Cereb. Blood Flow Metab., 12 (1992) 717-726.
42. Zhang, Z. and Iadecola, C., Reduction of focal cerebral ischemic damage by delayed treatment with nitric oxide donors, J. Cereb. Blood Flow Metab., 14 (1994) 574-580.
43. Zhang, F., White, J.G. and Iadecola, C., Nitric oxide donors increase blood flow and reduce brain damage in focal ischemia: evidence that nitric oxide is beneficial in the early stage of cerebral ischemia, J. Cereb. Blood Flow Metab., 14 (1994) 217-226.
44. Zhang, J., Benveniste, H., Klitzman, B. and Piantadosi, C.A., Nitric oxide synthase inhibition and extracellular glutamate concentration after cerebral ischemia/reperfusion, Stroke, 26 (1995) 298-304.